---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-22-000113"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T17:29:43.729478+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q3 revenue $83.2M (+18.1% YoY); net loss $0.27/share; guides FY2022 rev ~$328-333M

## Summary
- Revenue $83.2M, up 18.1% YoY (19.8% constant currency). US revenue $69.8M (+21.3%).
- Gross margin flat at 74.1%; operating loss $10.7M vs income $98.7M in Q3 2021 (includes non-recurring items).
- Adjusted EBITDA negative $0.7M vs positive $0.7M last year; adjusted EPS loss $0.27 vs $0.23.
- FY 2022 guidance: revenue ~$328-333M (20-21% growth), adjusted EBITDA loss ~$4M, adjusted loss per share ~$1.10-$1.12.
- Growth driven by cryoSPHERE pain management, AtriClip Flex·V, and EnCompass clamp; international growth in Australia and Japan.

## SEC filing metadata
- accession: 0001323885-22-000113
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388522000113/0001323885-22-000113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388522000113/atrc-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-22-000113
- JSON: https://secwatch.observer/filing/0001323885-22-000113.json
- Plain text: https://secwatch.observer/filing/0001323885-22-000113.txt

## Key facts
- Earnings Releases
  AtriCure, Inc. reported the third quarter ended September 30, 2022 results: revenue $83.2 million, EPS $0.27.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $83.2 million
  - EPS: $0.27
  - Result: reported results
  source text: Revenue for the third quarter 2022 was $83.2 million, an increase of 18.1% (an increase of 19.8% on a constant currency basis) over third quarter 2021 revenue.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388522000113/0001323885-22-000113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.